We are live on ! Find out more
SC

Searle & Co Portfolio holdings

AUM $398M
1-Year Est. Return 22.87%
This Fund
S&P 500
This Quarter Est. Return
+11.81%
1 Year Est. Return
+22.87%
3 Year Est. Return
+66.45%
5 Year Est. Return
+103%
10 Year Est. Return
+295.26%
AUM
$275M
AUM Growth
+$30.7M
Cap. Flow
+$4.43M
Cap. Flow %
1.61%
Top 10 Hldgs %
29.77%
Holding
162
New
14
Increased
13
Reduced
30
Closed
2

Top Buys

Rank Stock Value
1
CC icon
Chemours
CC
+$1.26M
2
WFC.PRL icon
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
+$746K
3
HRT
HireRight Holdings Corporation
HRT
+$594K
4
AES icon
AES
AES
+$523K
5
PLBY icon
Playboy Inc
PLBY
+$355K

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$298K
2
CDNA icon
CareDx
CDNA
+$228K
3
AAPL icon
Apple
AAPL
+$174K
4
IBM icon
IBM
IBM
+$168K
5
CL icon
Colgate-Palmolive
CL
+$117K

Sector Composition

Rank Sector Weight
1 Healthcare 19.94%
2 Technology 19.69%
3 Industrials 12.93%
4 Financials 9.86%
5 Consumer Discretionary 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TXN icon
101
Texas Instruments
TXN
$258B
$471K 0.17%
2,500
– –
CLX icon
102
Clorox
CLX
$11.6B
$461K 0.17%
2,646
– –
COP icon
103
ConocoPhillips
COP
$140B
$461K 0.17%
6,383
– –
UNP icon
104
Union Pacific
UNP
$179B
$437K 0.16%
1,733
– –
GCP
105
DELISTED
GCP Applied Technologies Inc.
GCP
$437K 0.16%
13,810
– –
HRTX icon
106
Heron Therapeutics
HRTX
$89.1M
$436K 0.16%
47,750
– –
NEM icon
107
Newmont
NEM
$95.8B
$434K 0.16%
6,990
– –
DGX icon
108
Quest Diagnostics
DGX
$23.3B
$433K 0.16%
2,500
– –
TAK icon
109
Takeda Pharmaceutical
TAK
$54.8B
$433K 0.16%
31,767
– –
INTC icon
110
Intel
INTC
$478B
$426K 0.16%
8,266
– –
TRV icon
111
Travelers Companies
TRV
$78.5B
$418K 0.15%
2,673
– –
INCY icon
112
Incyte
INCY
$23.4B
$415K 0.15%
5,650
– –
PSX icon
113
Phillips 66
PSX
$82.9B
$411K 0.15%
5,675
+2,134
+60% +$161K
GE icon
114
GE Aerospace
GE
$364B
$401K 0.15%
6,815
-149
-2% -$9.36K
SRE icon
115
Sempra
SRE
$60.3B
$397K 0.14%
6,000
– –
MDT icon
116
Medtronic
MDT
$106B
$395K 0.14%
3,819
– –
GLD icon
117
SPDR Gold Trust
GLD
$130B
$384K 0.14%
2,246
– –
BNY
118
Bank of New York Mellon
BNY
$108B
$378K 0.14%
6,500
– –
GIS icon
119
General Mills
GIS
$20.3B
$377K 0.14%
5,600
– –
UL icon
120
Unilever
UL
$134B
$377K 0.14%
6,222
– –
IMO icon
121
Imperial Oil
IMO
$59.2B
$361K 0.13%
10,000
– –
MU icon
122
Micron Technology
MU
$959B
$340K 0.12%
+3,650
New +$285K
EFA icon
123
iShares MSCI EAFE ETF
EFA
$76.5B
$336K 0.12%
4,269
– –
HII icon
124
Huntington Ingalls Industries
HII
$10.6B
$335K 0.12%
1,792
– –
CMCSA icon
125
Comcast
CMCSA
$85B
$333K 0.12%
6,608
– –
3 4
5
6 7

Similar funds

CF
Cypress Funds Los Angeles, California $398M AUM 8.77% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
DL
Dockside LLC New York $397M AUM
ECA
Elevated Capital Advisors Sandy, Utah $397M AUM 11.67% 1-Year Est. Return
BWM
BCGM Wealth Management Lafayette, Indiana $398M AUM 17.85% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return
LSA
Lansing Street Advisors Ambler, Pennsylvania $397M AUM 18.7% 1-Year Est. Return
THL
Tillman Hartley LLC Denver, Colorado $398M AUM 16.44% 1-Year Est. Return

Searle & Co's Q4 2021 Portfolio in Review

As of Q4 2021, Searle & Co held 162 positions worth $275M, up 13% from $244M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Searle & Co's Q4 2021 filing shows 14 new, 13 increased, 30 reduced and 2 closed positions. Its largest new stake was Chemours: 40,568 shares worth $1.36M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $298K.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 20% a quarter earlier, followed by Technology and Industrials.

  • Searle & Co's largest Q4 2021 buy was Chemours: 40,568 shares worth $1.36M.
  • Searle & Co added most to FedEx in Q4 2021, an estimated $216K increase.
  • Searle & Co's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $298K.
  • Searle & Co fully exited CareDx in Q4 2021, selling an estimated $228K.
  • Searle & Co's ten largest holdings make up 30% of its $275M portfolio in Q4 2021.
  • Searle & Co opened 14 new positions and closed 2 in Q4 2021.
  • Searle & Co's portfolio value rose 13% quarter-over-quarter to $275M.

Based on Searle & Co's 13F filing for Q4 2021, filed 19 Jan 2022.